|1.||Aminin, D L: 2 articles (01/2015 - 01/2013)|
|2.||Menchinskaya, E S: 2 articles (01/2015 - 01/2013)|
|3.||Avilov, Sergey A: 2 articles (10/2013 - 02/2009)|
|4.||Stonik, Valentin A: 2 articles (10/2013 - 02/2009)|
|5.||Pimenova, E A: 1 article (01/2015)|
|6.||Reunov, A A: 1 article (01/2015)|
|7.||Reunova, Yu A: 1 article (01/2015)|
|8.||Reunov, A V: 1 article (01/2015)|
|9.||Lapshina, L A: 1 article (01/2015)|
|10.||Andryjashchenko, Pelageya V: 1 article (10/2013)|
01/01/2013 - "The in vivo anticancer effect of cucumarioside A2-2 may be associated with the ability of the drug to arrest the cell cycle in the synthetic phase and induce programmed tumor cell death."
01/01/2013 - "The anticancer and proapoptotic properties of cucumarioside A2-2 may be due to direct interaction of the glycoside with tumor cells. "
01/01/2013 - "Cucumarioside A2-2 influences tumor cell viability at micromolar concentrations. "
10/01/2013 - "Inhibition of tumor cells multidrug resistance by cucumarioside A2-2, frondoside A and their complexes with cholesterol."
01/01/2013 - "The cytotoxicity of cucumarioside A2-2 and its effect on apoptosis, the cell cycle, DNA biosynthesis and p53 activity, and glycoside anticancer action against Ehrlich carcinoma cells were studied. "
01/01/2015 - "Cucumarioside A2-2 stimulates apoptotic necrosis in Ehrlich ascites carcinoma cells."
|3.||DNA (Deoxyribonucleic Acid)